The ID-Card DiaClon ABD-Confirmation for Patients can be used for the ABO/RhD blood group control of patients. Current recommendations for RhD typing suggest that, for transfusion recipients and antenatal patients, anti-D reagents should not detect the DVI phenotype. Individuals possessing the DVI phenotype may produce an anti-D to the missing epitopes after immunization by fetal or transfused RhD positive cells. To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned RhD negative status. Conversely, donor bloods should be tested with anti-D that does detect DVI and assigned RhD positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

ID-Card (Id-n°: 50053):
•Configuration: A, B, DVI-/A, B, DVI-
•Cell lines: A: LM297/628 (LA-2), B: LM306/686 (LB-2), D: TH28, RUM-1, LDM1

DiaClon ABD-Confirmation for Donors is used for the ABO/RhD blood group control of donors. Current recommendations for RhD typing suggest that, for transfusion recipients and antenatal patients, anti-D reagents should not detect the DVI phenotype. Individuals possessing the DVI phenotype may produce an anti-D to the missing epitopes after immunization by fetal or transfused RhD positive cells. To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned RhD negative status. Conversely, donor bloods should be tested with anti-D that does detect DVI and assigned RhD positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

ID-Card (Id-n°: 51051):
•Configuration: A, B, DVI+/A, B, DVI+
•Cell lines: A: LM297/628 (LA-2), B: LM306/686 (LB-2), D: ESD-1M, 175-2

To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned Rh negative status. Conversely, donor blood should be tested with anti-D that detects DVI, and assigned Rh positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

For the examination of previous transfusion records for the recipient’s serological history.

The results from the current testing must be compared with the interpretation of the previously determined blood group.

ID-Card (Id-n°: 50041):
•Human
•Configuration: A, B, D/A, B, D

The methods used in compatibility tests should include those that will demonstrate ABO and RhD incompatibility and detect clinically significant unexpected antibodies. The LISS/Coombs ID-Card allows major crossmatch test by the Indirect Antihumanglobulin test (IAT), and Autocontrol (IAT test).

ID-Card (Id-n°: 50531):
•Available in a selection of package sizes
•Configuration: 6 x AHG (Anti-IgG + C3d) tests, C3d: cell line C139-9

The ID-Card Coombs Anti-IgG consists of 6 microtubes containing anti-human globulin anti-IgG (rabbit), within the gel matrix.

ID-Card (Id-n°: 50540):
•Configuration: 6 x AHG (Anti-IgG), rabbit

The ID-Card NaCl, Enzyme Test and Cold Agglutinins is suitable for antibody screening and identification procedures, compatibility testing and reverse grouping.

It is not considered necessary to include the room temperature saline test in routine antibody screening procedures, but the saline test at 4°C can be used to detect cold agglutinins.

ID-Card (Id-n°: 50520):
•Available in a selection of package sizes
•Configuration: 6 tests

The methods used in compatibility tests should include those that will demonstrate ABO and RhD incompatibility and detect clinically significant unexpected antibodies. The ID-Card DiaClon Complete Crossmatch is configured to meet the above requirements in one easy step. It allows for ABD-confirmation of both donor and recipient, major crossmatch test by the Indirect Antihumanglobulin test (IAT), major enzyme crossmatch test, and Autocontrol (IAT test).

ID-Card (Id-n°: 50601):
•Configuration: A, B, DVI-/Enz./2 x AHG
•Cell lines: A: LM297/628 (LA-2), B: LM306/686 (LB-2),
D: LHM59/20 (LDM3), 175-2, AHG: rabbit, C3d: cell line C139-9

The methods used in compatibility tests should include those that will demonstrate ABO and RhD incompatibility and detect clinically significant, unexpected antibodies. The ID-Card Complete Crossmatch is configured to meet the above requirements in one easy step:
– ABD-confirmation of both donor and recipient
– Major crossmatch test by the Indirect Antihumanglobulin test (IAT)
– Major enzyme crossmatch test
– Autocontrol (IAT test)

ID-Card (Id-n°: 50591):
•Configuration: A, B, D/Enz./2 x AHG,
•Anti-A, Anti-B and Anti-D: human, AHG: rabbit, C3d: cell line C139-9